Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 29,900 shares at $51.31 ($1.5M) on 2020-04-24, disclosed to the SEC on 2020-04-24.
Open-market sale of $1.5M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.64 | 5,700 | $294K | 19.1% |
| 2 | $52.41 | 1,300 | $68K | 4.4% |
| 3 | $51.02 | 3,200 | $163K | 10.6% |
| 4 | $52.16 | 2,200 | $115K | 7.5% |
| 5 | $52.16 | 2,200 | $115K | 7.5% |
| 6 | $53.22 | 1,200 |
| $64K |
| 4.1% |
| 7 | $53.82 | 400 | $22K | 1.4% |
| 8 | $50.60 | 3,213 | $163K | 10.6% |
| 9 | $50.60 | 3,213 | $163K | 10.6% |
| 10 | $51.31 | 3,487 | $179K | 11.6% |
| 11 | $51.31 | 3,487 | $179K | 11.6% |
| 12 | $51.98 | 300 | $16K | 1.0% |
| Total | $51.48 avg | 29,900 | $1.5M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |